AFLAC Incorporated  

(Public, NYSE:AFL)   Watch this stock  
Find more results for AFL
+0.46 (0.79%)
Oct 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 57.87 - 58.63
52 week 54.99 - 67.62
Open 58.02
Vol / Avg. 1.07M/2.64M
Mkt cap 26.52B
P/E 9.25
Div/yield 0.37/2.53
EPS 6.33
Shares 453.05M
Beta 1.52
Inst. own 65%
Oct 29, 2014
Q3 2014 Aflac Incorporated Earnings Conference Call - 9:00AM EDT - Add to calendar
Oct 28, 2014
Q3 2014 Aflac Incorporated Earnings Release - 4:00PM EDT - Add to calendar
Sep 15, 2014
Aflac Inc Tokyo Financial Analyst Briefing
Jul 30, 2014
Q2 2014 Aflac Incorporated Earnings Conference Call
Jul 29, 2014
Q2 2014 Aflac Incorporated Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 13.81% 13.08%
Operating margin 22.49% 21.17%
EBITD margin - 26.73%
Return on average assets 2.59% 2.50%
Return on average equity 19.55% 20.64%
Employees 8,859 -
CDP Score - 85 B


United States - Map
+1-706-3233431 (Phone)
+1-706-3246330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Aflac Incorporated (Aflac) is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services. Its business is supplemental health and life insurance, through its subsidiary, American Family Life Assurance Company of Columbus, which operates in the United States and as a branch in Japan. Aflac�s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells voluntary supplemental insurance products including loss-of-income products and products designed to protect individuals from depletion of assets (hospital indemnity, fixed-benefit dental, vision care, accident, cancer, critical illness/ critical care, and hospital intensive care plans).

Officers and directors

Daniel P. Amos Chairman of the Board, Chief Executive Officer of the Company and Aflac
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kriss Cloninger III President, Chief Financial Officer, Treasurer, Director; Chief Financial Officer and EVP of Aflac
Age: 66
Bio & Compensation  - Reuters
Masahiko Furutani Deputy President of Aflac Japan
Age: 56
Bio & Compensation  - Reuters
Charles Ditmars Lake II Chairman of Aflac Japan, President of Aflac International
Age: 52
Bio & Compensation  - Reuters
Tohru Tonoike President, Chief Operating Officer of Aflac Japan
Age: 63
Bio & Compensation  - Reuters
Joey M. Loudermilk Executive Vice President, General Counsel of the Company and Aflac
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kenneth S. Janke Jr. Executive Vice President, Deputy Chief Financial Officer; President of Aflac U.S.
Age: 55
Bio & Compensation  - Reuters
Eric M. Kirsch Executive Vice President, Global Chief Investment Officer of Aflac
Age: 53
Bio & Compensation  - Reuters
Audrey Boone Tillman Executive Vice President - Corporate Services
Age: 49
Bio & Compensation  - Reuters
June P. Howard Senior Vice President - Financial Services, CAO of the Company and the Aflac; Treasurer of Aflac
Age: 47
Bio & Compensation  - Reuters